Abstract:Background: A number of oncoproteins and tumor suppressors are known to be neddylated, but whether the neddylation pathway is entirely activated in human cancer remains unexplored. Methods: NEDD8-activating enzyme (NAE) (E1) and NEDD8-conjugating enzyme (E2) expression and global-protein neddylation were examined by immunohistochemistry, immunoblotting, and real-time polymerase chain reaction analysis. Cell proliferation, clonogenic survival, migration, and motility in vitro, as well as tumor formation and metastasis in vivo, were determined upon neddylation inhibition by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Survival was analyzed with Kaplan-Meier methods and compared by the log-rank test. All statistical tests were two-sided. Results: The entire neddylation pathway, including NEDD8-activating enzyme E1, NEDD8-conjugating enzyme E2, and global-protein neddylation, is overactivated in both lung adenocarcinoma and squamous-cell carcinoma. Compared with lung adenocarcinoma patients with low expression, those with high expression had worse overall survival (NEDD8-activating enzyme E1 subunit 1 [NAE1]: hazard ratio [HR] = 2.07, 95% confidence interval [CI] = 0.95 to 4.52, P = .07; ubiquitin-conjugating enzyme E2M (UBC12): HR = 13.26, 95% CI = 1.77 to 99.35, P = .01; global protein neddylation: HR = 3.74, 95% CI = 1.65 to 8.47, P = .002). Moreover, inhibition of neddylation by the NAE inhibitor MLN4924 statistically significantly suppressed proliferation, survival, migration, and motility of lung cancer cells in vitro and tumor formation and metastasis in vivo. At the molecular level, MLN4924 inactivated Cullin-RING E3 ligases, led to accumulation of tumor-suppressive Cullin-RING E3 ligase substrates and induced phorbol-12-myristate-13-acetate-induced protein 1 (NOXA)-dependent apoptosis or cellular senescence. Conclusions: Our study highlights the overactivated neddylation pathway in lung cancer development and as a promising therapeutic target.

Identification of novel benzoyl hydrazine derivatives as activators of neddylation pathway to inhibit the tumor progression in vitro

Identification of novel benzothiazole derivatives as inhibitors of NEDDylation pathway to inhibit the progression of gastric cancer

Discovery of the 2,4-Disubstituted Quinazoline Derivative As a Novel Neddylation Inhibitor for Tumor Therapy

Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth in vitro and in vivo

Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression <i>in vitro</i> and <i>in vivo</i>

Development of Potent NEDD8-Activating Enzyme Inhibitors Bearing a Pyrimidotriazole Scaffold.

Discovery of Benzothiazole Derivatives As Novel Non-Sulfamide NEDD8 Activating Enzyme Inhibitors by Target-Based Virtual Screening.

Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy

Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy

Discovery of Candesartan Cilexetic As a Novel Neddylation Inhibitor for Suppressing Tumor Growth

Suppression of tumor angiogenesis by targeting the protein neddylation pathway.

Protein Neddylation and Its Alterations in Human Cancers for Targeted Therapy.

Progress in the researches for antitumor NEDD8 activating enzyme inhibitors

Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers

Neddylation-Independent Activities of MLN4924

Overactivated neddylation pathway as a therapeutic target in lung cancer

SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy

A Small Molecule Inhibitor of the UBE2F-CRL5 Axis Induces Apoptosis and Radiosensitization in Lung Cancer

Targeting cullin neddylation for cancer and fibrotic diseases

The Nedd8-activating Enzyme Inhibitor MLN4924 (Tak-924/Pevonedistat) Induces Apoptosis Via C-Myc-noxa Axis in Head and Neck Squamous Cell Carcinoma.

Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway